Lonza
Lonza offers a wide range of biologics, small molecule, cell and gene therapy, and health ingredient services, operating globally with a commitment to sustainability.
Biologics Services
Lonza offers a range of biologics services including mammalian and microbial biopharmaceuticals, antibody-drug conjugates (ADCs), and drug product manufacturing. These services encompass the entire lifecycle of biologics production, from development to commercial manufacturing. The company leverages its extensive experience and advanced technologies to support its clients in producing high-quality biologic drugs.
Small Molecule Services
Lonza provides comprehensive small molecule services that span from drug substance development to commercial production. The company specializes in highly potent active pharmaceutical ingredients (APIs) and offers innovative solutions for bioavailability enhancement. These services ensure that small molecule drugs are developed efficiently and effectively, from the initial phases through to their launch in the market.
Cell and Gene Therapy Services
Lonza operates a robust cell and gene therapy service portfolio which includes process development, current Good Manufacturing Practices (cGMP) manufacturing, and regulatory consulting. These services are designed to support the development and production of cell and gene therapies, ensuring compliance with regulatory standards and facilitating the path to commercialization.
Capsules and Health Ingredients Manufacturing
In the pharmaceutical and nutraceutical industries, Lonza manufactures capsules and health ingredients. The company offers a variety of solutions that meet the specific needs of its clients, ensuring that their products adhere to high-quality standards. This includes providing differentiated capsules and functional ingredients aimed at enhancing product efficacy and consumer appeal.
mRNA and LNP Development and Manufacturing
Lonza engages in mRNA and lipid nanoparticle (LNP) development and manufacturing, offering services that cover stages from pre-clinical development to commercial manufacturing. These cutting-edge services support the advancement of mRNA-based therapeutics, which have become crucial in modern medicine, providing comprehensive solutions to meet the biopharmaceutical industry's evolving needs.
Bioconjugates Services
The company provides specialized bioconjugates services, focusing primarily on antibody-drug conjugates (ADCs). Lonza offers end-to-end solutions from the early development stages through to commercial manufacturing. These services are crucial for the production of targeted therapies that combine the specificity of antibodies with the potency of cytotoxic drugs, aimed at treating various diseases.
Sustainability Initiatives
Lonza is committed to sustainability, with a range of initiatives aimed at reducing its environmental impact. These initiatives include targets for reducing energy consumption, waste production, and greenhouse gas emissions. The company’s dedication to sustainability underscores its efforts to contribute positively to the environment while maintaining high standards in manufacturing and service delivery.
Global Operations and Regulatory Expertise
With a network of facilities across North America, Europe, and Asia, Lonza operates on a global scale, providing extensive regulatory expertise and market access. Their comprehensive regulatory affairs services support clients through clinical trials, commercial applications, and product registration, ensuring that products meet the necessary regulatory requirements in various markets.